Terry Murdock
Directeur des opérations chez G1 THERAPEUTICS, INC.
Fortune : 400 043 $ au 30/04/2024
Postes actifs de Terry Murdock
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| G1 THERAPEUTICS, INC. | Directeur des opérations | 01/01/2019 | - |
| Corporate Officer/Principal | 03/08/2017 | - |
Historique de carrière de Terry Murdock
Anciens postes connus de Terry Murdock
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IQVIA HOLDINGS INC. | Corporate Officer/Principal | 01/09/2014 | 01/07/2017 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Directeur des opérations | 01/01/2001 | 01/05/2012 |
| The US Oncology Network | Corporate Officer/Principal | 01/01/1995 | 01/01/2001 |
| ERGOMED | Directeur Technique/Scientifique/R&D | - | - |
Formation de Terry Murdock
| The University of Texas at Austin | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| 2 | |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ERGOMED | Commercial Services |
| IQVIA HOLDINGS INC. | Health Services |
| Entreprise privées | 3 |
|---|---|
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
| G1 Therapeutics, Inc. | |
| The US Oncology Network |
- Bourse
- Insiders
- Terry Murdock
- Expérience
